Unlock instant, AI-driven research and patent intelligence for your innovation.

An acylated derivative of resiquimod, its preparation method and application

A technology for resiquimod and derivatives, which is applied in the field of anti-melanoma acylated derivatives of resiquimod and its preparation, and achieves the effects of strong selectivity, good clinical application value and good activity

Active Publication Date: 2020-09-29
INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although Resiquimod has been shown to be 10-100 times stronger than imiquimod in T cell activation, it has not been approved for clinical use by the FDA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An acylated derivative of resiquimod, its preparation method and application
  • An acylated derivative of resiquimod, its preparation method and application
  • An acylated derivative of resiquimod, its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] This embodiment provides an acylated derivative (B) of Resiquimod, the structure is as follows:

[0029]

[0030] The acylated derivative of the Resiquimod is prepared by the following method, the method comprising the steps of:

[0031] 1) Under ice-bath conditions, dissolve 47.2mg (0.15mMol, mw=314) resiquimod in 10ml of chloroform, add 51mg of triethylamine and 2mg of 4-dimethylaminopyridine to it, and then slowly drop Acetyl chloride in chloroform to obtain a mixed solution;

[0032] Wherein, in the chloroform solution of described acetyl chloride, 40mg acetyl chloride is dissolved in 1ml chloroform;

[0033] 2) Stir the mixture at a temperature of 25° C. until new spots appear on the TLC spot plate during TLC detection, and then add ice water to quench the reaction;

[0034] 3) In the reaction liquid of quenching reaction, adopt 10ml ethyl acetate to extract reaction liquid 3 times respectively, after liquid separation, take organic phase; After adopting anhyd...

Embodiment 2

[0038] Oral squamous cell carcinoma cells SCC-15 and human tongue carcinoma cell carcinoma cells CAL-27 were subjected to RPMI containing 10% fetal bovine serum, 1 million units of penicillin and 800,000 units of streptomycin at 37°C, 5% CO2 and saturated humidity. Cultured in 1640 complete culture medium, subcultured (frozen storage if necessary). Take two lines of oral squamous cell carcinoma SCC-15 and human tongue squamous cell CAL-27 in the logarithmic growth phase, digest with trypsin, collect the suspension, centrifuge (1000r, 4min), discard the supernatant, add the culture medium and count the cells , diluted to a concentration of 5×104 cells / ml, added to a 96-well plate, 100ul per well.

[0039] After cultivating overnight, the original culture solution was removed, and Resiquimod and Resiquimod acylated derivative B (the Resiquimod acylated derivative made in Example 1) were added to the experimental group respectively. The final concentration was 200ug / ml, 100ug / ml,...

Embodiment 3

[0047]Human melanoma cells A875 and malignant melanoma cells WM 451Lu were fully cultured in RPMI 1640 containing 10% fetal bovine serum, 1 million units of penicillin and 800,000 units of streptomycin at 37°C, 5% CO2 and saturated humidity. Cultivate and subculture in liquid (frozen storage if necessary). Take two strains of human melanoma cells A875 and malignant melanoma cells WM451Lu in the logarithmic growth phase, digest with trypsin, collect the suspension, centrifuge (1000r, 4min), discard the supernatant, add the culture medium and count the cells, dilute to a concentration of 5×104 cells / ml, add to 96-well plate, 100ul per well.

[0048] After culturing overnight, remove the original culture medium, and add Resiquimod and Resiquimod acylated derivative B culture medium with final concentrations of 200ug / ml, 100ug / ml, 50ug / ml, 25ug / ml, and 10ug / ml to the experimental group respectively, and the negative control group Add complete medium. After acting for 48 hours, r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an acylated derivative of resiquimod, a preparation method and the application thereof. The general formula of the acylated derivative of resiquimod is as shown in the specification, wherein R1 is selected from one of benzoyl, acetyl, formyl, phenylacetyl and hydrogen; and R2 is selected from one of benzoyl, formyl, hydrogen and acetyl. The acylated derivative of resiquimod provided by the invention has good activity application for oral cancer cells and melanoma cells, and has good clinic application values. The acylated derivative of resiquimod has obvious effects inthe application for curing oral cancer and melanoma.

Description

technical field [0001] The invention relates to the field of chemicals and chemical synthesis, in particular to an acylated derivative used for anti-melanoma resiquimod and a preparation method thereof. Background technique [0002] Oral cancer is a serious and growing global malignancy. Due to the high prevalence and incidence of oral cancer, it has become a major public health problem. Oral cancer is the sixth most common tumor in the world. There are 263,000 new cases of oral cancer and nearly 130,000 deaths each year. Western countries are areas with a high incidence of oral cancer, and the infection rate of oral cancer is gradually increasing and attracting attention. China is a country with a large population and a large number of people. The prevention and treatment of oral cancer and effective drug development are very important. At present, the clinical treatment methods for oral cancer mainly include surgery, radiation therapy, chemotherapy and combination therap...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04A61P35/00
CPCC07D471/04
Inventor 黄林芳李本汉曹雨丁嘉冀徐小威刘书静
Owner INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI